Chenrui Li
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Pharmacology top 5%
- Flavonoids in Medical Research
Papers in
-
- Mitochondrial Function and Pathology 7
- Heme Oxygenase-1 and Carbon Monoxide 3
- Inflammasome and immune disorders 3
- Cell Biology 11
- Endoplasmic Reticulum Stress and Disease 9
- Co-authors
- Zhong Zuo (3 shared papers)Ge Lin (3 shared papers)Lin Sun (26 shared papers)Ming Yang (22 shared papers)Yachun Han (21 shared papers)Hao Zhao (17 shared papers)Shilu Luo (19 shared papers)Jinfei Yang (12 shared papers)
In The Last Decade
Chenrui Li
46 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 100
- Nephrology 119
- Pharmacology 222
- Cell Biology 187
- Clinical Biochemistry 72
- Complementary and alternative medicine 60
Countries citing papers authored by Chenrui Li
This map shows the geographic impact of Chenrui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenrui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenrui Li more than expected).
Fields of papers citing papers by Chenrui Li
This network shows the impact of papers produced by Chenrui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenrui Li. The network helps show where Chenrui Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenrui Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 216 | |
| 2 | 2020 | 111 | |
| 3 | 2019 | 74 | |
| 4 | 2022 | 71 | |
| 5 | 2020 | 66 | |
| 6 | 2021 | 60 | |
| 7 | 2011 | 48 | |
| 8 | 2023 | 45 | |
| 9 | 2022 | 39 | |
| 10 | 2021 | 33 | |
| 11 | 2021 | 29 | |
| 12 | 2020 | 28 | |
| 13 | 2021 | 26 | |
| 14 | 2021 | 26 | |
| 15 | 2020 | 22 | |
| 16 | 2023 | 21 | |
| 17 | 2022 | 21 | |
| 18 | 2020 | 21 | |
| 19 | 2023 | 18 | |
| 20 | 2023 | 17 |
About Chenrui Li
Chenrui Li is a scholar working on Molecular Biology, Cell Biology, Epidemiology, Pharmacology and Pathology and Forensic Medicine, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include Endoplasmic Reticulum Stress and Disease (9 papers), Autophagy in Disease and Therapy (8 papers), Mitochondrial Function and Pathology (7 papers), Genetic and Kidney Cyst Diseases (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers), Flavonoids in Medical Research (3 papers) and Inflammasome and immune disorders (3 papers). The work is most often cited by research in Nephrology (119 citations), Pharmacology (222 citations), Cell Biology (187 citations), Clinical Biochemistry (72 citations) and Complementary and alternative medicine (60 citations). Chenrui Li has collaborated with scholars based in China, Hong Kong and Ghana. Frequent co-authors include Zhong Zuo, Ge Lin, Lin Sun, Ming Yang, Yachun Han, Hao Zhao, Shilu Luo, Jinfei Yang, Na Jiang and Ying Xiao. Their work appears in journals such as Frontiers in Endocrinology, Molecular Medicine, Frontiers in Pharmacology, Current Medicinal Chemistry and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.